Ausun Pharma Overview

  • Founded
  • 2010

Founded
  • Status
  • Public

  • Employees
  • 846

Employees
  • Stock Symbol
  • 603229

Stock Symbol
  • Investments
  • 1

  • Share Price
  • $6.89

  • (As of Wednesday Closing)

Ausun Pharma General Information

Description

Zhejiang Ausun Pharmaceutical Co Ltd is mainly engaged in the research and development, production and sales of specialty APIs and pharmaceutical intermediates, as well as providing customized production and research for customers. Its products portfolio includes Prostaglandins and their intermediates, Raw material medicine, Fluorine series and Develop products.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Stock Exchange
SHG
Primary Office
  • Number 5, Donghai 4th Avenue
  • Zhejiang Chemcial Materials Base Zone
  • Linhai, Zhejiang 317016
  • China
+86 0576 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ausun Pharma Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$6.89 $6.26 $2.65 - $9.94 $2.52B 402M 20.6M $0.07

Ausun Pharma Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 2,555,627 1,546,367 1,296,125 427,464
Revenue 98,189 88,228 59,238 44,563
EBITDA 29,175 28,666 16,596 11,639
Net Income 26,893 22,600 12,569 8,161
Total Assets 305,349 288,583 211,484 126,650
Total Debt 26,565 17,247 6,282 6,426
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Ausun Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ausun Pharma‘s full profile, request access.

Request a free trial

Ausun Pharma Patents

Ausun Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210047339-A1 Method for preparation of asenapine Pending 13-Aug-2019 00000000000
JP-2020511508-A Method for synthesizing eliglutat and its intermediate compounds Pending 21-Mar-2017 0000000000
EP-3611171-A1 Method for synthesis of eliglustat and intermediate compounds thereof Pending 21-Mar-2017 0000000000
US-20200031808-A1 Process for synthesis of eliglustat and intermediate compounds thereof Pending 21-Mar-2017 0000000000
EP-3611171-A4 Method for synthesis of eliglustat and intermediate compounds thereof Pending 21-Mar-2017 C07D405/06 0
To view Ausun Pharma’s complete patent history, request access »

Ausun Pharma Executive Team (1)

Name Title Board Seat Contact Info
Zhiguo Zheng Chairman & General Manager
To view Ausun Pharma’s complete executive team members history, request access »

Ausun Pharma Board Members (1)

Name Representing Role Since
Zhiguo Zheng Ausun Pharma Chairman & General Manager 000 0000
To view Ausun Pharma’s complete board members history, request access »

Ausun Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ausun Pharma Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000 27-Jul-2020 00000 0000 0000 Drug Discovery
To view Ausun Pharma’s complete investments history, request access »